Lars Erik Steinkjer, Nora Bratheim and Guro S. Kyrkjebø Nybø have contributed to the Norwegian chapter in the Chambers and Partners Life Sciences & Pharma IP Litigation 2024 Global Practice Guide.

The EU’s Artificial Intelligence (AI) Act marks a global first, introducing rules for the use and provision of AI systems. At the heart is a commitment to fostering trust in AI to unlock and maximise the vast social and ­economic possibilities offered by these technologies.

On Friday 8 December, after 36 hours of trialogue negotiations, the European institutions finally reached agreement on the AI Act. A joint press conference was held on 9 December where the two  lead MEPs, the Secretary of State for digitalisation and artificial intelligence, and the EU Commissioner in charge presented the key elements of the agreement.

The proposal for regulating artificial intelligence by the European Commission marks a global first, introducing a comprehensive legal structure in this domain. This Act targets both AI system providers and users, emphasising significant penalties for non-compliance — potentially up to 40 million Euros or 7% of the total annual turnover. This underscores the importance of adherence to these regulations. At the heart of the Act is a commitment to fostering trust in artificial intelligence, a cornerstone deemed essential for unlocking and maximising the vast social and economic possibilities offered by AI technologies

Wikborg Rein is a contributing firm to the Life Science & Pharma IP Litigation 2023 with Chambers and Partners.

Update on the implementation of the SPC manufacturing waiver for pharmaceutical manufacturers into Norwegian law.

The European Union's new Digital Services Act aims to create a safer digital space for citizens and businesses. The regulation seeks to provide for greater democratic control and supervision of digital platforms, and to reduce the risk of manipulation, disinformation and illegal content.

Artificial Intelligence

Consumer, marketing and e-commerce

Intellectual Property

International Trade

Life sciences and healthcare

Offshore

Dispute Resolution

Partner

Lars Erik has extensive experience assisting clients in intellectual property rights (IPR) matters, including advice on securing, licensing and enforcing intellectual property rights. 

Lars Erik assists our clients with strategic advice, drafting and negotiation of agreements. He has been involved in a number of major disputes related to the enforcement of intellectual property rights and assists both international and domestic companies before the Norwegian courts.

Lars Erik is a board member and vice-chair of NIR (the Norwegian Association for the Protection of Industrial Property) and the Norwegian AIPPI board.

Oslo

{"title":{"title":"Lars Erik Steinkjer | Wikborg Rein"}}

Lars Erik has extensive experience assisting clients in intellectual property rights (IPR) matters, including advice on securing, licensing and enforcing intellectual property rights.